🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Sumitomo Pharma Co., Ltd. (TYO:4506)
Japan flag Japan · Delayed Price · Currency is JPY
1,842.50
-53.00 (-2.80%)
Nov 20, 2026, 9:20 AM JST

Sumitomo Pharma Cash Flow Statement

Millions JPY. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
46,243106,86523,634-314,929-96,71440,600
Depreciation & Amortization
18,42419,12823,27437,76541,26338,348
Other Amortization
1,6581,6582,288---
Loss (Gain) From Sale of Assets
-50,990-49,043-13,537180,85775,850769
Asset Writedown & Restructuring Costs
2,0732,0735,189---
Loss (Gain) From Sale of Investments
45,850-3,193-2,568-5,890-24,735-
Other Operating Activities
14,47311,199-3,010-37,226-25,236-41,871
Change in Accounts Receivable
-29,662-50,774-90923,39051,218-6,097
Change in Inventory
-6,0899,00518,837-11,7954,5605,356
Change in Accounts Payable
19,38724,431-25,8685,6455,318-28,669
Change in Unearned Revenue
-13,153-13,153-25,822---
Change in Other Net Operating Assets
22,14913,51914,992-119,710-19,58722,803
Operating Cash Flow
70,36371,71516,500-241,89311,93731,239
Operating Cash Flow Growth
134.75%334.64%---61.79%-76.96%

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-2,826-4,609-8,498-10,771-8,467-7,347
Sale of Property, Plant & Equipment
1094492,2084341,3221,313
Cash Acquisitions
-3,340-4,008-267---
Divestitures
-30,4771,4588,60530,172-
Sale (Purchase) of Intangibles
-1,877-2,703-4,532-4,9597,840-6,147
Investment in Securities
3,0582,741106,84629,7273,821-6,433
Other Investing Activities
3262022,539-2,047-797
Investing Cash Flow
-4,55022,54999,75433,03652,419-18,278

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
---84,00085,55929
Long-Term Debt Issued
--146,187---
Total Debt Issued
--146,18784,00085,55929
Short-Term Debt Repaid
--4,400-181,972---
Long-Term Debt Repaid
--86,540-73,614--20,060-4,960
Lease Payments
-2,540-2,540-3,614---
Total Debt Repaid
-126,540-90,940-255,586--20,060-4,960
Net Debt Issued (Repaid)
-126,540-90,940-109,39984,00065,499-4,931
Common Dividends Paid
-2-2-3-2,792-11,125-11,126
Other Financing Activities
-50-324566-3,357-201,191-5,369
Financing Cash Flow
-29,717-91,266-108,83677,851-146,817-21,426

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
3,1735,024-17715,44024,09017,751
Miscellaneous Cash Flow Adjustments
---13,1721,135-1,135-
Net Cash Flow
39,2698,022-5,931-114,431-59,5069,286

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
67,53767,1068,002-252,6643,47023,892
Free Cash Flow Growth
193.41%738.62%---85.48%-81.56%
Free Cash Flow Margin
13.71%14.80%2.01%-80.32%0.63%4.27%
Free Cash Flow Per Share
160.91168.9120.14-635.978.7360.14
Levered Free Cash Flow
16,90365,7075,270-253,96245,98815,575
Unlevered Free Cash Flow
20,17969,0608,132-251,52947,63817,431
Free Cash Flow After Leases
64,99764,5664,388-252,6643,47023,892

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
3,3414,4914,3613,7342,4242,500
Cash Income Tax Paid
9534,564-12,18237,59525,45042,331
Change in Working Capital
-7,368-16,972-18,770-102,47041,509-6,607